NEW YORK (GenomeWeb) – Quality control and cost are key issues in running any successful clinical lab. With the US Food and Drug Administration weighing increased oversight over laboratory-developed tests, and the Centers for Medicare & Medicaid Services moving closer to implementing rules expected to reduce Medicare payments to clinical labs, the issues of clinical lab costs and quality control are attracting even more scrutiny.

Get the full story with
360Dx Premium

Only $95 for the
first 90 days*

360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try 360Dx Premium now.

You may already have institutional access!

Check if I qualify.

Already a 360Dx or GenomeWeb Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.